
PathoPrint helps clinicians and researchers quickly assess bacterial resistance and tailor treatments. It uses machine learning models, bioinformatics, and real-world microbiology data to power AMR prediction and precision antibiotic recommendations. The platform targets hospitals, labs, and pharmaceutical companies as a B2B AI analytics solution. Key technologies include AI/ML, bioinformatics pipelines, and AMR analysis to support data-driven decision making. The company also focuses on AI-driven drug discovery to accelerate the development of next-gen antibiotics.

PathoPrint helps clinicians and researchers quickly assess bacterial resistance and tailor treatments. It uses machine learning models, bioinformatics, and real-world microbiology data to power AMR prediction and precision antibiotic recommendations. The platform targets hospitals, labs, and pharmaceutical companies as a B2B AI analytics solution. Key technologies include AI/ML, bioinformatics pipelines, and AMR analysis to support data-driven decision making. The company also focuses on AI-driven drug discovery to accelerate the development of next-gen antibiotics.